Thomas O. Daniel
2014
In 2014, Thomas O. Daniel earned a total compensation of $7.7M as Chairman, Celgene Research at Celgene, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $4,141,720 |
|---|---|
| Option Awards | $1,921,324 |
| Salary | $691,500 |
| Stock Awards | $767,672 |
| Other | $148,364 |
| Total | $7,670,580 |
Daniel received $4.1M in non-equity incentive plan, accounting for 54% of the total pay in 2014.
Daniel also received $1.9M in option awards, $691.5K in salary, $767.7K in stock awards and $148.4K in other compensation.
Rankings
In 2014, Thomas O. Daniel's compensation ranked 826th out of 13,032 executives tracked by ExecPay. In other words, Daniel earned more than 93.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 826 out of 13,032 | 94th |
Division Manufacturing | 300 out of 4,965 | 94th |
Major group Chemicals And Allied Products | 99 out of 1,690 | 94th |
Industry group Drugs | 77 out of 1,369 | 94th |
Industry Pharmaceutical Preparations | 70 out of 1,042 | 93rd |
Source: SEC filing on April 28, 2016.
Daniel's colleagues
We found six more compensation records of executives who worked with Thomas O. Daniel at Celgene in 2014.
2014
Robert Hugin
Celgene
Chief Executive Officer
2014
Peter Kellogg
Celgene
Chief Financial Officer
2014
Jacqualyn Fouse
Celgene
President Hematology and Oncology
2014
Mark Alles
Celgene
Chief Operating Officer
2014
Perry Karsen
Celgene
Chief Executive Officer
2014
Scott Smith
Celgene